Search Within

Omar Ibrahim Abdel-Wahab

  1. "Surgery"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (9)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (20)
  2. Department of Medicine (20)
  3. Executive Committee, Center for Hematologic Malignancies (20)
  4. GSK Faculty (20)
  5. Hematologic Malignancies, Division of (20)
  6. Surgery (20)

More Groups

People
  1. Benjamin Durham (11)
  2. Eli Diamond (10)
  3. Mario Lacouture (9)
  4. Kseniya Petrova-Drus (8)
  5. Mariko Yabe (8)
  6. Veronica Rotemberg (8)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (1)
  6. 2020 (1)

More Years

Publications
  1. Blood (3)
  2. Nature Medicine (3)
  3. British Journal of Haematology (2)
  4. Pediatric Blood and Cancer (2)
  5. BJU International (1)
  6. Cancer Immunology Research (1)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. American Society of Hematology (3)
  3. American Association for Cancer Research (2)
  4. John Wiley & Sons (2)
  5. Wiley Blackwell (2)
  6. Wiley Periodicals, Inc (2)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs
    Journal Article

    Krishnamoorthy, G. P.; Glover, A. R.; Untch, B. R.; Sigcha-Coello, N.; Xu, B.; Vukel, D.; Liu, Y.; Tiedje, V.; Pineda, J. M. B.; Berman, K.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Augmenting CAR T-cell functions with LIGHT
    Journal Article

    Cai, W.; Tanaka, K.; Mi, X.; Rajasekhar, V. K.; Khan, J. F.; Yoo, S.; de Stanchina, E.; Rahman, J.; Mathew, S.; Abrahimi, P.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society
    Meeting Abstract

    Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
    Research Letter

    Diamond, E. L.; Francis, J. H.; Lacouture, M. E.; Rotemberg, V.; Yabe, M.; Petrova-Drus, K.; Ulaner, G. A.; Reddy, R.; Abdel-Wahab, O.; Durham, B. H.
    Leukemia (2023)

    Fulltext@MSK | Save
  • Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • RBM10 loss in thyroid cancer leads to aberrant splicing of cytoskeletal and extracellular matrix mRNAs and increased metastatic fitness
    Meeting Abstract

    Krishnamoorthy, G. P.; Glover, A.; Untch, B.; Saqcena, M.; Vukel, D.; Berman, K.; Abdel-Wahab, O.; Bradley, R. K.; Knauf, J. A.; Fagin, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save